Posted by Michael Wonder on 28 Jul 2021
FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
28 July 2021 - Availability of insulin products will help increase access and potentially lower the cost of insulin for people with diabetes.
Today, the U.S. FDA approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and paediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
